Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-25-003039
Filing Date
2025-03-17
Accepted
2025-03-17 07:18:30
Documents
106
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K plx-20241231x10k.htm   iXBRL 10-K 2324469
2 EX-4.4 plx-20241231xex4d4.htm EX-4.4 18805
3 EX-19 plx-20241231xex19.htm EX-19 104246
4 EX-21.1 plx-20241231xex21d1.htm EX-21.1 4654
5 EX-23.1 plx-20241231xex23d1.htm EX-23.1 7594
6 EX-31.1 plx-20241231xex31d1.htm EX-31.1 11324
7 EX-31.2 plx-20241231xex31d2.htm EX-31.2 10953
8 EX-32.1 plx-20241231xex32d1.htm EX-32.1 5554
9 EX-32.2 plx-20241231xex32d2.htm EX-32.2 5461
10 GRAPHIC plx-20241231x10k001.jpg GRAPHIC 33083
11 GRAPHIC plx-20241231x10k002.jpg GRAPHIC 45532
12 GRAPHIC plx-20241231x10k003.jpg GRAPHIC 58451
13 GRAPHIC plx-20241231x10k004.jpg GRAPHIC 52258
14 GRAPHIC plx-20241231x10k005.jpg GRAPHIC 38492
15 GRAPHIC plx-20241231x10k006.jpg GRAPHIC 38391
16 GRAPHIC plx-20241231x10k007.jpg GRAPHIC 56626
17 GRAPHIC plx-20241231x10k008.jpg GRAPHIC 40218
18 GRAPHIC plx-20241231x10k010.jpg GRAPHIC 3480
19 GRAPHIC plx-20241231xex23d1001.jpg GRAPHIC 4679
  Complete submission text file 0001558370-25-003039.txt   10516382

Data Files

Seq Description Document Type Size
20 EX-101.SCH plx-20241231.xsd EX-101.SCH 60233
21 EX-101.CAL plx-20241231_cal.xml EX-101.CAL 62803
22 EX-101.DEF plx-20241231_def.xml EX-101.DEF 240880
23 EX-101.LAB plx-20241231_lab.xml EX-101.LAB 467007
24 EX-101.PRE plx-20241231_pre.xml EX-101.PRE 429522
109 EXTRACTED XBRL INSTANCE DOCUMENT plx-20241231x10k_htm.xml XML 1557308
Mailing Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601
Business Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601 201-696-9345
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33357 | Film No.: 25742338
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)